ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,875Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 199

$1.27M Total Retail Price of All Prescriptions

Rank: 5 out of 199

839 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 839 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 839 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 1,583 1,378 204 1 1
SIMVASTATIN 1,096 1,017 163 2 2
OMEPRAZOLE 898 817 144 3 4
AMLODIPINE BESYLATE 804 718 102 4 3
METFORMIN HCL 684 583 87 5 13
POTASSIUM CHLORIDE 642 603 95 6 10
GABAPENTIN 589 499 103 7 14
FUROSEMIDE 529 475 86 8 5
MELOXICAM 511 479 108 9 32
TRAMADOL HCL 507 445 117 10 16
CITALOPRAM HBR 505 422 72 11 20
METOPROLOL TARTRATE 482 443 74 12 12
WARFARIN SODIUM 476 418 58 13 7
GLIMEPIRIDE 428 334 56 14 38
LISINOPRIL 389 352 63 15 6
TAMSULOSIN HCL 386 342 59 16 26
HYDROCHLOROTHIAZIDE 379 358 55 17 17
ALENDRONATE SODIUM 352 347* 51 18 29
ATORVASTATIN CALCIUM 343 304 56 19 8
HYDROCODONE-ACETAMINOPHEN 335 269 87 S3 20 9
ZOLPIDEM TARTRATE 313 252 52 21 28
METOPROLOL SUCCINATE 302 262 45 22 11
PANTOPRAZOLE SODIUM 263 240 45 23 25
DONEPEZIL HCL 254 241 37 24 30
NAMENDA 251 251 28 25 34
NEXIUM 250 192 39 26 46
ALLOPURINOL 240 210 27 27 22
LYRICA 229 180 29 28 82
PREDNISONE 225 193 57 29 33
CLONAZEPAM 224 160 32 B 30 55
ATENOLOL 221 200 33 31 19
ENALAPRIL MALEATE 221 178 27 31 65
LEVOFLOXACIN 217 190 148 33 80
ESCITALOPRAM OXALATE 209 187 27 34 36
BYSTOLIC 206 206 25 35 54
CRESTOR 205 174 30 36 31
CLOPIDOGREL 194 168 24 37 27
CARVEDILOL 190 173 31 38 21
AZITHROMYCIN 186 148 133 39 68
LOSARTAN POTASSIUM 183 178* 28 40 15
BUMETANIDE 172 143 37 41 101
AMLODIPINE BESYLATE-BENAZEPRIL 163 151 19 42 98
ADVAIR DISKUS 154 111 22 43 51
AMITRIPTYLINE HCL 149 138 21 R 44 75
FLUTICASONE PROPIONATE 140 135* 44 45 35
BENAZEPRIL HCL 131 119 18 46 48
RAMIPRIL 130 118 16 47 79
OXYCODONE-ACETAMINOPHEN 126 87 28 S2 48 87
PRAVASTATIN SODIUM 125 101 20 49 18
LANTUS SOLOSTAR 124 107 20 50 71
VENLAFAXINE HCL ER 123 74 16 51 76
ROPINIROLE HCL 123 118* 16 51 74
SPIRONOLACTONE 122 109 25 53 39
ALPRAZOLAM 118 102 22 B 54 24
METHYLPREDNISOLONE 118 106 95 54 153
SPIRIVA 116 100 17 56 69
DIOVAN 114 90 16 57 42
POLYETHYLENE GLYCOL 3350 111 106* 35 58 45
VESICARE 110 95 20 59 67
FENOFIBRATE* 106 101* 17 60 59
FAMOTIDINE* 99 87 11 61 64
EXELON 97 97 13 62 105
CYMBALTA 96 91* 15 63 44
LANTUS 96 <11 <11 63 60
ISOSORBIDE MONONITRATE ER 96 72 14 63 66
PROPRANOLOL HCL 95 78 14 66 94
TEMAZEPAM 92 61 14 B 67 116
IRBESARTAN 89 84* 11 68 161
AVODART 87 82* 12 69 209
CELEBREX 87 64 16 69 63
MONTELUKAST SODIUM 83 <11 <11 71 58
FLUDROCORTISONE ACETATE 82 82 12 72 236
METOCLOPRAMIDE HCL 81 64 20 73 150
FENTANYL 79 74* 14 S2 74 77
OLANZAPINE 78 <11 <11 A 75 191
PREMARIN 75 70* 14 R 76 121
DICLOFENAC SODIUM 75 59 13 76 199
TIZANIDINE HCL 73 48 37 78 130
LORAZEPAM 71 46 15 B 79 40
DILTIAZEM ER 69 <11 <11 80 141
LOSARTAN-HYDROCHLOROTHIAZIDE 69 <11 <11 80 49
EXFORGE 68 <11 <11 82 219
VALSARTAN-HYDROCHLOROTHIAZIDE 68 <11 <11 82 83
BENICAR 67 62* 12 84 92
MECLIZINE HCL 67 62* 26 84 152
KLOR-CON 10 65 52 11 86 134
CEFDINIR 65 60* 54 86 253
TRAZODONE HCL 65 <11 <11 86 50
DIVALPROEX SODIUM 63 <11 <11 89 124
PROPAFENONE HCL 62 <11 <11 90 257
SERTRALINE HCL 62 <11 <11 90 23
AMIODARONE HCL 60 55* 14 92 111
DIGOXIN 60 <11 <11 92 106
GLIPIZIDE 57 <11 <11 94 61
METFORMIN HCL ER 56 <11 <11 95 62
TRIAMTERENE-HCTZ 55 50* 11 96 37
PROAIR HFA 54 19 13 97 81
CARBIDOPA-LEVODOPA 54 <11 <11 97 88
BUSPIRONE HCL 54 <11 <11 97 129
ONDANSETRON HCL* 53 28 25 100 198
DICYCLOMINE HCL 52 52 13 101 190
NAPROXEN 51 <11 <11 102 176
OXYBUTYNIN CHLORIDE ER 51 <11 <11 102 102
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 <11 <11 104 43
TRADJENTA 50 <11 <11 104 291
DETROL LA 50 <11 <11 104 159
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.